Equities

Avinger Inc

AVGR:NAQ

Avinger Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.94
  • Today's Change-0.09 / -4.43%
  • Shares traded31.39k
  • 1 Year change-78.37%
  • Beta1.1456
Data delayed at least 15 minutes, as of Jun 06 2024 20:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).

  • Revenue in USD (TTM)7.62m
  • Net income in USD-16.13m
  • Incorporated2007
  • Employees68.00
  • Location
    Avinger Inc400 Chesapeake DrREDWOOD CITY 94063-4739United StatesUSA
  • Phone+1 (650) 363-2400
  • Fax+1 (302) 655-5049
  • Websitehttps://avinger.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tivic Health Systems Inc1.13m-7.61m2.55m9.00--0.2819--2.25-11.17-11.171.021.460.21840.923717.31126,000.00-146.51---194.55--30.07---670.99--2.07--0.00---36.09--18.34------
Tenon Medical Inc3.21m-14.33m2.62m21.00--8.07--0.8138-7.24-7.241.430.97240.41082.787.25153,047.60-183.10---269.43--54.70---445.77--2.35--0.00--323.73--17.63------
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.67m24.00------8.00-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
VirExit Technologies Inc0.00-1.80m2.84m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Vycor Medical Inc1.44m-425.52k2.94m8.00------2.04-0.0133-0.01350.0425-0.10781.590.66726.81179,572.50-11.22-47.86----89.4889.60-7.04-35.420.0861-0.0247----19.43-0.654246.49---31.77--
Invo Bioscience Inc4.25m-7.08m3.28m25.00------0.7709-5.68-5.682.590.00390.34739.5030.72169,953.20-57.87-94.63-128.00-151.4539.9074.91-166.64-343.110.1629-5.860.9965--267.3843.6226.24--87.09--
Venus Concept Inc73.30m-37.39m3.37m304.00------0.046-6.69-6.6913.12-3.540.74091.062.21241,125.00-37.61-32.71-56.83-44.0168.3768.16-50.77-48.501.35-3.441.40---23.2628.3114.76---35.08--
Helius Medical Technologies Inc-100.00bn-100.00bn3.57m26.00--0.6304----------2.24-----------98.37---143.57--37.27---1,580.663.26-------18.176.1437.11------
Heart Test Laboratories Inc18.60k-6.39m3.61m12.00--40.52--193.86-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Avinger Inc7.62m-16.13m3.65m68.00------0.479-18.16-18.167.49-2.560.40841.206.38112,102.90-102.83-70.93---131.5722.4330.87-251.78-208.910.4764-10.021.38---7.51-0.673632.76---24.21--
Catheter Precision Inc439.00k-6.85m3.79m14.00--0.2044--8.63-1.03-1.030.06592.450.01150.37595.7431,357.14-17.89---19.64--94.31---1,559.68--0.8047--0.004--3,057.14---165.67------
Therapeutic Solutions International Inc98.99k-2.17m4.13m3.00--3.04--41.75-0.0007-0.00070.000030.00030.02871.134.4432,996.67-64.51-162.32-169.11--62.8567.79-2,247.41-2,391.850.0333-4.920.373---52.1395.3543.11------
Nu-Med Plus Inc0.00-119.16k4.18m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
SINTX Technologies Inc2.78m-8.88m4.45m43.00--0.0189--1.60-389.94-389.9474.21383.240.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
Vapotherm Inc70.07m-54.94m4.70m182.00------0.0671-8.62-8.6211.00-11.020.81221.467.53385,011.00-63.68-49.73-587.27-62.5445.2843.56-78.40-78.990.1259-1.272.59--2.8010.1448.62---10.38--
Nuwellis Inc8.90m-19.93m4.73m59.00--2.01--0.5317-8.30-8.302.730.13040.70761.557.04150,762.70-143.62-98.07-216.07-122.4857.4155.22-202.97-230.510.7092-4.750.00--3.7612.14-55.78--4.61--
Data as of Jun 06 2024. Currency figures normalised to Avinger Inc's reporting currency: US Dollar USD

Institutional shareholders

1.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202423.80k1.40%
BlackRock Fund Advisorsas of 31 Mar 20245.61k0.33%
Tower Research Capital LLCas of 31 Mar 20241.04k0.06%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024252.000.02%
City State Bank (Norwalk, Iowa) (Investment Management)as of 31 Mar 2024225.000.01%
HighMark Wealth Management LLCas of 31 Mar 2024127.000.01%
Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 2024115.000.01%
Securities America Advisors, Inc.as of 31 Mar 202434.000.00%
Qube Research & Technologies Ltd.as of 31 Mar 202411.000.00%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 202411.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.